Inovio will be included in the special poster session of the conference. Stand by for more details and further updates on INO's presence at the conference as they become available.
The IMV conference series offers a regular update on the developments/issues surrounding ‘immunopotentiators for modern vaccines’ and is a vital aspect of the
growth of this important area of vaccinology.
IMV 2014 will once again offer an international forum to review the current state of research and developments/applications of immunopotentiators/adjuvants for modern
vaccines and associated vaccine programmes/strategies. IMV 2014 will be of interest to researchers involved in determining the mechanisms of adjuvant function and
responses and optimising these responses, manufacturers of biologicals, those involved in the manufacture/licensing of injectable biologicals, and those interested in the
control of infectious and non/infectious diseases
conference link
Squamous cell cancer originates from the middle layer, and is less common but more likely to spread and, if untreated, become fatal. Melanoma, which originates in the pigment-producing cells (melanocytes), is the least common, but most aggressive, most likely to spread and, if untreated, become fatal.
ReplyDelete